| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |